← Back to the fund page Use your browser's print dialog and choose “Save as PDF”. A4, two pages.
InvestVerdict

Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund

Regular Plan · Growth · Index Funds · Scheme code 148557

Fund houseEdelweiss Mutual Fund
CategoryIndex Funds
Plan & optionRegular · Growth
History5.8 years

Returns (%)

 1M3M6M1Y3Y5Y7Y10YLaunch
This scheme 1.3111.8913.41 24.1719.8313.69 16.50
Nifty 100
benchmark
0.253.49-1.52 1.8410.529.38 12.79
Index Funds
category median
5.597.638.89 11.16

Over a year annualised (CAGR), under a year absolute. Computed from AMFI's published NAV history for this scheme.

Risk

 VolatilitySharpeSortinoBetaAlphaMax fall
This scheme 11.6% 1.15 1.70 0.51 6.19% -16.7% 32.16
Nifty 100
benchmark
17.1%0.23 0.32 -37.0%

Risk-free rate 6.5%. Beta, alpha and R² are regressed on the 69 months this scheme and its benchmark share.

Growth of ₹100 since launch

89144199255202220242026InvestVerdict

Drawdown from peak (%)

0%-5%-11%-16%202220242026

Every one-year period it has lived through

WindowsWorstMedianBestPeriods that lost money
230 -9.9% 11.9% 47.9% 20%

Every one-year holding period in this scheme's history, not just the last one — the spread a real investor would have met depending only on when they started.

InvestVerdict

Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund

Regular Plan · Growth

Concentration

Number of stocks0
Top 5 stocks
Top 10 stocks
Top 20 stocks
Largest holding
Largest sector— —
Effective stocks
Cash0.00%
InvestVerdict

Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund

Regular Plan · Growth · holdings

A ₹10,000 monthly SIP over five years

InvestedValueGainXIRR
₹600,000 ₹946,907 ₹346,907 18.32%

XIRR, not CAGR — a SIP's money arrives over sixty months, so each instalment has been invested for a different length of time.

Not investment advice. InvestVerdict is not a SEBI-registered Investment Adviser or Research Analyst. Every figure is computed from AMFI's published NAV history and the portfolio the AMC filed with AMFI; none of it is a recommendation to buy, hold or sell. Past returns do not predict future ones. Generated 29 Aug 2026.